Sort
39,280 grants matching “leukemia”
BCLW in lymphoma survival and resistance to targeted BCL2 family therapies
$429,800Christine M Eischen · Thomas Jefferson University · R01 · FY2021 · CA
BCLW in lymphoma survival and resistance to targeted BCL2 family therapies
$429,800Christine M Eischen · Thomas Jefferson University · R01 · FY2020 · CA
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML
$429,758Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML
$429,758Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
The role of ATM in the suppression of lymphoid malignancy
$429,756Shan Zha · Columbia University Health Sciences · R01 · FY2024 · CA
The role of ATM in the suppression of lymphoid malignancy
$429,756Shan Zha · Columbia University Health Sciences · R01 · FY2025 · CA
Hepatitis B virus integrations in KMT2B drive hepatocellular carcinoma
$429,744Jian Cao · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
A stalled chromatin regulatory network that mediates the oncogenic activity of Meningioma-1
$429,710Kathrin M Bernt · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Regulation and function of HOX genes in Ewing sarcoma pathogenesis
$429,693Elizabeth R Lawlor · Seattle Children'S Hospital · R01 · FY2021 · CA
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22
$429,683Kevin M Shannon · University Of Chicago · P01 · FY2008 · CA
Project 3 - Genomics of Secondary AML Progression.
$429,668Matthew J Walter · Washington University · P01 · FY2023 · CA
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
$429,649Robert Sackstein · Florida International University · U01 · FY2021 · CA
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Enhancing neutrophil function in neutropenia-related pneumonia
$429,583Hongbo R Luo · Boston Children'S Hospital · R01 · FY2010 · HL
Biology and Prognostic Implications of FLT3 Mutations in AML
$429,543Soheil Meshinchi · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Leukemia stem cell polarity and differentiation therapy
$429,520James C Mulloy · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$429,511Deborah V Novack · Ohio State University · P01 · FY2023 · CA
Augmenting Antitumor Immunity
$429,477Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2014 · CA
Severe Chronic Neutropenia International Registry
$429,469David Chandler Dale · University Of Washington · R24 · FY2006 · AI
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
$429,402Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · AI
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
$429,402Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · AI
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
$429,402Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · AI
Southern Oncology Network on Adverse Reactions (SONAR) - Focus on Tyrosine Kinase
$429,384Charles Lee Bennett · University Of South Carolina At Columbia · R01 · FY2016 · CA
Design of inhibitors of drug-resistance protein kinases
$429,357Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Target-specific inhibition and activation of protein tyrosine phosphatases
$429,337Anthony C Bishop · Amherst College · R15 · FY2016 · GM